Tutkijat / Oulu  | Ala-Kokko, L. |
| Ala-Kokko, T(ero) |
| Ala-Korpela, M(ika) |
| Alahuhta, S. |
| Alen, M. |
| Antikainen, R. |
| Anttonen, V(uokko) |
| Biancari, F(austo) |
| Bloigu, R(isto) |
| Eskelinen, S. |
| Flinkkilä, T(apio) |
| Hakkola, J. |
| Hallman, M. |
| Hartikainen, A(nna)-L(iisa) |
| Hausen, H. |
| Hautala, N(ina) |
| Hautala, T(imo) |
| Heape, A. |
| Herzig, K(arl)-H(einz) |
| Hillbom, M. |
| Hiltunen, J.K. |
| Hörkko, S. |
| Huikuri, H(eikki) |
| Hukkanen J(anne) |
| Ignatius, J. |
| Isohanni, M. |
| Jaakkola, J. |
| Jaakkola, M(aritta) S. |
| Jaakola, V-P. |
| Jämsä, T(imo) |
| Janhonen, S. |
| Järvelin, M(arjo)-R(iitta) |
| Jokelainen, J(ari) |
| Juffer, A.H. |
| Junttila, J(uhani) |
| Juvonen, T. |
| Kaarteenaho, R(iitta) |
| Kajantie, E(ero)*(THL/OY) |
| Karppinen (Koivunen), P(eppi) |
| Karppinen, J(aro) |
| Karttunen, T.J. |
| Keinänen-Kiukaanniemi, S(irkka) |
| Kerkelä, R(isto) |
| Kesäniemi, Y.A. |
| Kettunen, J(ohannes) |
| Kietzmann, T(homas). |
| Kivirikko, K.I. |
| Knuuttila, M. |
| Koivukangas, J. |
| Kursula, P. |
| Kyngäs, H. |
| Larivaara, P. |
| Larmas, M. |
| Lehenkari, P(etri) |
| Lehtiö, L(ari) |
| Leppilahti, J. |
| Luukinen, H. |
| Mainio A |
| Majamaa, K. |
| Mäki, P(irjo) |
| Mäkikallio, T(imo) H. |
| Männikkö, M(inna) |
| Manninen, A(ki). |
| Martikainen, H(annu) |
| Miettunen, J(ouko) |
| Myllyharju, J. |
| Myllylä, R. |
| Myllylä, V. |
| Näyhä, S. |
| Neubauer, P. |
| Nieminen, M(iika) T. |
| Nieminen, P(entti) |
| Niinimäki, J(aakko) |
| Ohukainen, P(auli) |
| Oikarinen, A. |
| Oikarinen, K. |
| Pelkonen, O(lavi) |
| Petäjä-Repo, U.E. |
| Pihlajaniemi, T. |
| Pirttiniemi, P(ertti) |
| Puistola, U(lla) |
| Rajaniemi, H.J. |
| Rämet, M(ika) |
| Räsänen, P. |
| Raustia, A. |
| Remes, A(nne) |
| Risteli, J. |
| Ristiniemi, J. |
| Ruddock, L.W. |
| Ruokonen, A. |
| Ruskoaho, H. |
| Ryynänen, M. |
| Saarakkala, S. |
| Saari, A. |
| Salo, T(uula) |
| Sándor, G(eorge) K. |
| Savolainen, E-R. |
| Savolainen, M.J. |
| Savolainen, O. |
| Sillanpää, M(ikko). |
| Soininen, R. |
| Sorri, M. |
| Taanila, A. |
| Tapiainen, T(erhi) |
| Tervonen, O(smo) |
| Timonen, M(arkku) |
| Tjäderhane, L. |
| Turpeenniemi-Hujanen, T. |
| Tuukkanen, J(uha) |
| Tuulonen, A. |
| Uhari, M. |
| Ukkola, O(lavi) |
| Uusimaa, J. |
| Vainio, O. |
| Vainio, S. |
| Väyrynen, J(uha) P. |
| Veijola, J(uha) |
| Veijola, R(iitta) |
| Virokannas, H. |
| Voipio, H(anna)-M(arja) |
| Vuolteenaho, O. |
| Weckström, M. |
| Wei, GH. |
| Wierenga, R.K. |
| Winqvist, R(obert) |
| Ylänne, J. |
| Ylitalo, K(ari) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | The amino-terminal oligomerization domain of Angiopoietin-2 affects vascular remodeling, mammary gland tumor growth, and lung metastasis in mice. | Pihlajaniemi, T. | 14 days | save |  |  |  | |
| Lack of collagen XVIII leads to lipodystrophy and perturbs hepatic glucose and lipid homeostasis. | Pihlajaniemi, T. | 152 days | save | | | | |
| Exploring the roles of MACIT and Multiplexin collagens in stem cells and cancer. | Pihlajaniemi, T. | 417 days | save | | | | |
| Stromal integrinα11 regulates PDGFR-β signaling and promotes breast cancer progression. | Pihlajaniemi, T. | 473 days | save | | | | |
| Toward understanding scarless skin wound healing and pathological scarring. | Pihlajaniemi, T. | 489 days | save | | | | |
| Collagen XIII-derived ectodomain regulates bone angiogenesis and intracortical remodeling. | Pihlajaniemi, T. | 493 days | save | | | | |
| Collagen XVIII Deposition in the Basement Membrane Zone beneath the Newly Forming Epidermis during Wound Healing in Mice. | Pihlajaniemi, T. | 549 days | save | | | | |
| Collagen XIII and Other ECM Components in the Assembly and Disease of the Neuromuscular Junction. | Pihlajaniemi, T. | 604 days | save | | | | |
| Correct expression and localization of collagen xiii is crucial for the normal formation and function of the neuromuscular system. | Pihlajaniemi, T. | 641 days | save | | | | |
| The N-terminal Domain of Unknown Function (DUF959) in Collagen XVIII is Intrinsically Disordered and Highly O-glycosylated. | Pihlajaniemi, T. | 738 days | save | | | | |
| Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance. | Pihlajaniemi, T. | 752 days | save | | | | |
| Collagen XIII is required for neuromuscular synapse regeneration and functional recovery after peripheral nerve injury. | Pihlajaniemi, T. | 931 days | save | | | | |
| 2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors. | Pihlajaniemi, T. | 1001 days | save | | | | |
| Expression of a specific extracellular matrix signature is a favorable prognostic factor in acute myeloid leukemia. | Pihlajaniemi, T. | 1037 days | save | | | | |
| Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways. | Pihlajaniemi, T. | 1050 days | save | | | | |
| Understanding the extracellular matrix in acute myeloid leukemia. | Pihlajaniemi, T. | 1093 days | save | | | | |
| Vanin 1 (VNN1) levels predict poor outcome in acute myeloid leukemia. | Pihlajaniemi, T. | 1117 days | save | | | | |
| Autoimmune antibodies to collagen XIII in myasthenia gravis patients. | Pihlajaniemi, T. | 1142 days | save | | | | |
| An extracellular matrix signature in leukemia precursor cells and acute myeloid leukemia. | Pihlajaniemi, T. | 1288 days | save | | | | |
| Collagen XIII secures pre- and postsynaptic integrity of the neuromuscular synapse. | Pihlajaniemi, T. | 1300 days | save | | | | |
| Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma. | Pihlajaniemi, T. | 1312 days | save | | | | |
| GATA4-dependent organ-specific endothelial differentiation controls liver development and embryonic hematopoiesis. | Pihlajaniemi, T. | 1341 days | save | | | | |
| Lack of collagen XV is protective after ischemic stroke in mice. | Pihlajaniemi, T. | 1381 days | save | | | | |
| Highly potent and isoform-selective dual-site-binding tankyrase/Wnt signaling inhibitors that increase cellular glucose uptake and have anti-proliferative activity. | Pihlajaniemi, T. | 1408 days | save | | | | |
| Collagen XVIII in tissue homeostasis and dysregulation - Lessons learned from model organisms and human patients. | Pihlajaniemi, T. | 1468 days | save | | | | |
| Small-Molecule Chemical Probe Rescues Cells from Mono-ADP-Ribosyltransferase ARTD10/PARP10-Induced Apoptosis and Sensitizes Cancer Cells to DNA Damage. | Pihlajaniemi, T. | 1489 days | save | | | | |
| Editorial: Wound healing and fibrosis-two sides of the same coin. | Pihlajaniemi, T. | 1547 days | save | | | | |
| Elevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin Tumors. | Pihlajaniemi, T. | 1557 days | save | | | | |
| Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney. | Pihlajaniemi, T. | 1626 days | save | | | | |
| Absence of collagen XVIII in mice causes age-related insufficiency in retinal pigment epithelium proteostasis. | Pihlajaniemi, T. | 1639 days | save | | | | |
| Continuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept Study. | Pihlajaniemi, T. | 1734 days | save | | | | |
| Membrane-associated collagens with interrupted triple-helices (MACITs): evolution from a bilaterian common ancestor and functional conservation in C. elegans. | Pihlajaniemi, T. | 1774 days | save | | | | |
| Collagens xv and XVIII show different expression and localisation in cutaneous squamous cell carcinoma: type XV appears in tumour stroma while XVIII becomes up-regulated in tumour cells and lost from microvessels. | Pihlajaniemi, T. | 1776 days | save | | | | |
| Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences. | Pihlajaniemi, T. | 1879 days | save | | | | |
| Discovery of potent and selective nonplanar tankyrase inhibiting nicotinamide mimics. | Pihlajaniemi, T. | 1926 days | save | | | | |
| Endostatin induces proliferation of oral carcinoma cells but its effect on invasion is modified by the tumor microenvironment. | Pihlajaniemi, T. | 1947 days | save | | | | |
| EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma. | Pihlajaniemi, T. | 2046 days | save | | | | |
| Neural ECM and synaptogenesis. | Pihlajaniemi, T. | 2165 days | save | | | | |
| Basement Membrane Zone Collagens XV and XVIII/Proteoglycans Mediate Leukocyte Influx in Renal Ischemia/Reperfusion. | Pihlajaniemi, T. | 2242 days | save | | | | |
| Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers. | Pihlajaniemi, T. | 2258 days | save | | | | |
| Specific collagen XVIII isoforms promote adipose tissue accrual via mechanisms determining adipocyte number and affect fat deposition. | Pihlajaniemi, T. | 2293 days | save | | | | |
| [Many dimensions of extracellular matrix research]. | Pihlajaniemi, T. | 2503 days | save | | | | |
| Image based assessment of microvascular function and structure in Collagen XV and XVIII deficient mice. | Pihlajaniemi, T. | 2538 days | save | | | | |
| Collagen XVIII Short Isoform Is Critical for Retinal Vascularization, and Overexpression of the Tsp-1 Domain Affects Eye Growth and Cataract Formation. | Pihlajaniemi, T. | 2563 days | save | | | | |
| para-Substituted 2-Phenyl-3,4-dihydroquinazolin-4-ones As Potent and Selective Tankyrase Inhibitors. | Pihlajaniemi, T. | 2565 days | save | | | | |
| Discovery of Tankyrase Inhibiting Flavones with Increased Potency and Isoenzyme Selectivity. | Pihlajaniemi, T. | 2567 days | save | | | | |
| Expression of VEGF and collagen XVIII in meningiomas: correlations with histopathological and MRI characteristics. | Pihlajaniemi, T. | 2742 days | save | | | | |
| Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma. | Pihlajaniemi, T. | 2874 days | save | | | | |
| Endostatin, an Inhibitor of Angiogenesis, Decreases After Bidirectional Superior Cavopulmonary Anastamosis. | Pihlajaniemi, T. | 2966 days | save | | | | |
| Target-Derived Matricryptins Organize Cerebellar Synapse Formation through?3?1 Integrins. | Pihlajaniemi, T. | 2994 days | save | | | | |
| | 
report | next » | | |
|
